Enmark Exim (India) Private Limited
About Enmark Exim (India) Private Limited
Data last updated:
Enmark Exim (India) Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 19 July 1995 and has been in existence for over 31 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24110TG1995PTC021083. Its GSTIN is 36AAACE4426H1ZV (Telangana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹6 Lakh. It is led by directors Venkateswara Rao Palacharla and Venkata Sambasiva Rao Tummala.
Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at #202 Satya Sai Residency No.7 – 1 – 54/1 Dharam Karan Road Ameerper, Hyderabad, Telangana, India – 500016.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.65 Cr, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹10.43 Lakh (net margin 6.3%) and EBITDA of ₹20.87 Lakh (EBITDA margin 12.7%). Revenue has grown at a compounded annual rate (CAGR) of 14% over three years and 3% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Enmark Exim (India) has one previous CIN (Corporate Identification Number): U24110AP1995PTC021083. The current CIN is U24110TG1995PTC021083, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24110TG1995PTC021083 | Current |
| U24110AP1995PTC021083 | Previous |
Contact details
Enmark Exim (India) Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address#202 Satya Sai Residency No.7 – 1 – 54/1 Dharam Karan Road Ameerper, Hyderabad, Telangana, India – 500016
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Enmark Exim (India) Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Enmark Exim (India) is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Enmark Exim (India) Private Limited, buy the company report.
Financials of Enmark Exim (India) Private Limited
FY 2025 filings availableEnmark Exim (India) Private Limited reported revenue of ₹1.65 Cr (up 10% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 3% over five years, including 10% growth in the latest year. EBITDA fell 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹20.87 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹10.43 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 12.7% | ||||
| Net Profit Margin | 6.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Enmark Exim (India) Private Limited, buy the company report.
Board of directors of Enmark Exim (India) Private Limited
Enmark Exim (India) has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Venkateswara Rao Palacharla Also directs: PVR Infratech India Private Limited | Director | 21 Sep 2021 | 5 Years 1 Months | Current |
| Venkata Sambasiva Rao Tummala | Director | 24 Feb 2020 | 6 Years 8 Months | Current |
Auditor
Enmark Exim (India) Private Limited is audited by BALAJINAIDU AND CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BALAJINAIDU AND CO | FY 2023 | 006676S |
Shareholding
The shareholding of Enmark Exim (India) Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Enmark Exim (India) Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Enmark Exim (India) Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Enmark Exim (India) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Enmark Exim (India) has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAACE4426H1ZV | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Enmark Exim (India) Private Limited, buy the company report.
Recent activity
Enmark Exim (India) Private Limited has 8 board changes on record since 2004: 5 appointments and 3 cessations. The latest: Kamineni Vivekananda ceased to be Director on 25 Sep 2021.
Frequently asked questions
Enmark Exim (India) is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 19 July 1995 (31+ years old) and is registered under CIN U24110TG1995PTC021083.
Enmark Exim (India) has 2 current directors:
- Venkateswara Rao Palacharla - Director
- Venkata Sambasiva Rao Tummala - Director
The latest financial statements of Enmark Exim (India) on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 27 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Enmark Exim (India) is 36AAACE4426H1ZV, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Enmark Exim (India) is U24110TG1995PTC021083. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Enmark Exim (India) was incorporated on 19 July 1995, making it 31+ years old. It is registered with the Registrar of Companies, Hyderabad.
Kamineni Vivekananda ceased to be Director on 25 Sep 2021. Venkateswara Rao Palacharla was appointed as Director on 21 Sep 2021. Nikhil Kosuri ceased to be Director on 26 Feb 2020. Enmark Exim (India) has 8 board changes on record in total.
The registered office of Enmark Exim (India) is at #202 Satya Sai Residency No.7 – 1 – 541 Dharam Karan Road Ameerper, Hyderabad, Telangana, India – 500016.
Enmark Exim (India) operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Enmark Exim (India) is compliant as of 26 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
